Y

Yili Chuanning Biotechnology Co Ltd
SZSE:301301

Watchlist Manager
Yili Chuanning Biotechnology Co Ltd
SZSE:301301
Watchlist
Price: 12.8 CNY -5.26% Market Closed
Market Cap: 28.5B CNY
Have any thoughts about
Yili Chuanning Biotechnology Co Ltd?
Write Note

Net Margin
Yili Chuanning Biotechnology Co Ltd

23.5%
Current
20%
Average
-7.6%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
23.5%
=
Net Income
1.3B
/
Revenue
5.6B

Net Margin Across Competitors

Country CN
Market Cap 28.5B CNY
Net Margin
23%
Country FR
Market Cap 6T USD
Net Margin
-21 040%
Country US
Market Cap 312.7B USD
Net Margin
9%
Country US
Market Cap 158.3B USD
Net Margin
13%
Country US
Market Cap 115.9B USD
Net Margin
-5%
Country US
Market Cap 112.4B USD
Net Margin
0%
Country US
Market Cap 94.1B EUR
Net Margin
-392%
Country AU
Market Cap 133.6B AUD
Net Margin
18%
Country US
Market Cap 82.6B USD
Net Margin
34%
Country US
Market Cap 39.3B EUR
Net Margin
-33%
Country NL
Market Cap 34.5B EUR
Net Margin
-14%
No Stocks Found

Yili Chuanning Biotechnology Co Ltd
Glance View

Market Cap
28.5B CNY
Industry
Biotechnology

Yili Chuanning Biotechnology Co., Ltd. engages in biological fermentation, chemical extraction, enzymatic hydrolysis, energy saving, and environmental protection technology. The company is headquartered in Yili Hasake, Xinjiang and currently employs 2,779 full-time employees. The company went IPO on 2022-12-27. The firm's products mainly include erythromycin thiocyanate, cephalosporin intermediates, penicillin intermediates, crude ursodeoxycholic acid, coenzyme Q10 mycelium and others. The firm's products are mainly exported to countries such as India.

Intrinsic Value
16.92 CNY
Undervaluation 24%
Intrinsic Value
Price
Y

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
23.5%
=
Net Income
1.3B
/
Revenue
5.6B
What is the Net Margin of Yili Chuanning Biotechnology Co Ltd?

Based on Yili Chuanning Biotechnology Co Ltd's most recent financial statements, the company has Net Margin of 23.5%.